GALECTIN THERAPEUTICS INC - COM NEW (GALT)

Historical Holders from Q1 2014 to Q1 2025

Symbol
GALT on Nasdaq
CUSIP
363225202
Type / Class
Equity / COM NEW
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
8.9M
Holdings value
$11.4M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
98
Number of buys
50
Number of sells
-16
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 230K $280K -$40.1K $1.22 10
2024 Q4 8.9M $11.4M -$40.5K $1.29 98
2024 Q3 9.75M $26.8M +$625K $2.75 84
2024 Q2 9.42M $21.3M +$4.01M $2.26 71
2024 Q1 7.59M $18.1M +$1.19M $2.39 58
2023 Q4 7.2M $12M -$3.13M $1.66 65
2023 Q3 9.02M $17.3M +$3.46M $1.92 57
2023 Q2 7.25M $10.4M +$114K $1.44 57
2023 Q1 7.15M $15M +$220K $2.10 55
2022 Q4 5.82M $6.57M +$182K $1.13 55
2022 Q3 5.62M $9.16M -$200K $1.63 50
2022 Q2 4.99M $6.53M -$575K $1.31 51
2022 Q1 6.19M $9.95M -$322K $1.61 51
2021 Q4 7.32M $15.1M -$497K $2.07 50
2021 Q3 7.2M $27.9M -$2.18M $3.88 66
2021 Q2 6.55M $21M -$5M $3.20 69
2021 Q1 9.39M $20.4M -$1.72M $2.17 67
2020 Q4 10.7M $23.8M +$478K $2.24 72
2020 Q3 9.98M $26.7M -$295K $2.67 63
2020 Q2 8.21M $25.1M +$906K $3.06 70
2020 Q1 9.68M $19M -$1.08M $1.96 71
2019 Q4 10M $28.7M +$1.84M $2.86 73
2019 Q3 9.37M $34.4M +$3.09M $3.67 74
2019 Q2 8.48M $35.2M +$4.36M $4.15 71
2019 Q1 6.61M $33.8M +$9.06M $5.11 61
2018 Q4 5.06M $17.4M -$2.42M $3.43 56
2018 Q3 6.01M $35.8M +$1.92M $6.01 59
2018 Q2 5.57M $35.5M +$4.18M $6.36 65
2018 Q1 4.96M $23.5M +$6.15M $4.74 55
2017 Q4 3.73M $12.5M -$433K $3.34 45
2017 Q3 3.79M $8.08M +$14.3K $2.13 43
2017 Q2 3.97M $9.77M +$859K $2.46 46
2017 Q1 3.53M $8.13M +$1.93M $2.30 37
2016 Q4 2.84M $2.78M -$227K $0.98 33
2016 Q3 3.03M $3.42M -$601K $1.13 39
2016 Q2 3.49M $5.12M -$570K $1.47 42
2016 Q1 3.48M $4.96M -$243K $1.43 39
2015 Q4 3.55M $5.83M +$1.25M $1.64 45
2015 Q3 2.58M $6.04M -$1.4M $2.34 38
2015 Q2 3.14M $8.58M -$2.04M $2.73 51
2015 Q1 4.05M $13.6M +$949K $3.35 56
2014 Q4 3.75M $13M -$3.08M $3.47 57
2014 Q3 4.28M $21.5M -$4.78M $5.03 60
2014 Q2 4.24M $58.6M +$9.16M $13.81 62
2014 Q1 3.47M $53.1M +$31.9M $15.31 49